Outpatient Biofeedback in Addition to Home Pelvic Floor Muscle Exercises

August 1, 2016 updated by: Fatima Fitz, Federal University of São Paulo

Outpatient Biofeedback in Addition to Home Pelvic Floor Muscle Training for Stress Urinary Incontinence: a Randomized Controlled Trial

To test whether biofeedback (BF) added to pelvic floor muscle training (PFMT) promotes additional benefits over PFMT alone in the stress urinary incontinence (SUI) treatment.

Study Overview

Detailed Description

Introduction: The aim of this study was to test the hypothesis that outpatient BF added to home PFMT results in increased frequency of home exercises sets per month performed by the patients and objective cure rate after 3 months of supervised training. Secondarily, to investigate other subjective and objective clinical parameters in the groups that received or not BF together with PFMT after 3 months of supervised training, and in a longer term of 9-month follow-up.

Method: 72 incontinent women were randomized to the: BF Group (outpatient BF + home PFMT) or PFMT Group (outpatient PFMT + home PFMT).

Assessments: baseline after 3 months of supervised treatment and at 9-month follow-up (after 6 additional months of home PFMT without supervision).

Primary outcomes: adherence - monthly exercises sets performed (exercise diary) and objective cure of SUI (pad test) after 3 months.

Secondary outcomes: urinary symptoms, muscle function, quality of life, adhesion and subject cure at the two time-points.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • SUI and mixed urinary incontinence with predominant symptoms of SUI with ≥ 2 g of leakage measured by pad test

Exclusion Criteria:

  • younger than 18 years old
  • chronic degenerative diseases
  • pelvic organ prolapse greater than stage I by POP-Q
  • neurologic or psychiatric diseases
  • previously undergone pelvic floor re-education programs and/or previous pelvic floor surgeries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BF group
24 outpatient sessions of the PFMT (twice a week) using manometric-based BF equipment and daily home PFMT exercises.
24 outpatient sessions PFMT with biofeedback (twice a week). Simultaneously, it was prescribed a home exercise daily program during three months (supervised treatment).
Other Names:
  • Biofeedback
Active Comparator: PFMT group
24 outpatient sessions (twice a week) of PFMT without BF and daily home PFMT exercises.
24 outpatient sessions PFMT without biofeedback (twice a week). Simultaneously, it was prescribed a home exercise daily program during three months (supervised treatment).
Other Names:
  • PFMT alone

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pad test
Time Frame: Baseline, after 3 months of supervised treatment and at 9-month follow-up
To quantify the severity of SUI and as the tool to estimate objective cure rate
Baseline, after 3 months of supervised treatment and at 9-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in 7-Day Voiding Diary
Time Frame: Baseline, after 3 months of supervised treatment and at 9-month follow-up
To assess the loss efforts
Baseline, after 3 months of supervised treatment and at 9-month follow-up
Change in pelvic floor muscle function (Oxford Grading Scale)
Time Frame: Baseline, after 3 months of supervised treatment and at 9-month follow-up
To assess the function of the pelvic floor muscle
Baseline, after 3 months of supervised treatment and at 9-month follow-up
Change in pelvic floor muscle function (Peritron manometer)
Time Frame: Baseline, after 3 months of supervised treatment and at 9-month follow-up
To assess the function of the pelvic floor muscle
Baseline, after 3 months of supervised treatment and at 9-month follow-up
Change in Incontinence Quality-of-Life Questionnaire (I-QoL)
Time Frame: Baseline, after 3 months of supervised treatment and at 9-month follow-up
To quantify the impact of SUI on quality of life
Baseline, after 3 months of supervised treatment and at 9-month follow-up
Subjective cure of SUI ("satisfied" or "dissatisfied")
Time Frame: After 3 months of supervised treatment and at 9-month follow-up
To evaluate the patient satisfaction with treatment
After 3 months of supervised treatment and at 9-month follow-up
Frequency and adhesion to the home exercises
Time Frame: After 3 months of supervised treatment and at 9-month follow-up
The weekly frequency (days/week that patients performed at least 1 set of exercises) and the number of sets per day
After 3 months of supervised treatment and at 9-month follow-up
Frequency of the outpatient sessions
Time Frame: After 3 months of supervised treatment
The frequency of the outpatient sessions was monitored
After 3 months of supervised treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fatima F Fitz, M.Sc, Federal University of São Paulo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

March 1, 2011

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

July 28, 2016

First Submitted That Met QC Criteria

July 28, 2016

First Posted (Estimate)

August 2, 2016

Study Record Updates

Last Update Posted (Estimate)

August 3, 2016

Last Update Submitted That Met QC Criteria

August 1, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The individual participant data (IPD) collected in this study are being analyzed by the researchers to be available.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Incontinence, Stress

Clinical Trials on PFMT with biofeedback + Home PFMT

Subscribe